EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Eosinophilic Depletion with Benralizumab, Mepolizumab, and Depemokimab: A Modeling Study

Pradeep B Lukka iD, Robert C Penland iD, Ari Brekkan, Rami Ayoun Alsoud, Sherri So iD, David W Boulton iD

Journal of Asthma and Allergy · 2026-05 · Volume 19 · 1-5

DOI: 10.2147/jaa.s605634 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Asthma and Allergy, 2026-05. Verfasst von Pradeep B Lukka und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacology & Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gaithersburg, MD, USA. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

asthmahumaninterleukin-5monoclonal antibodiespharmacodynamicspharmacokinetics

Autor:innen und Institutionen

  • Clinical Pharmacology & Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Pharmetheus, Uppsala, Sweden.
  • BioPharmaceutials Medical, AstraZeneca, Gaithersburg, MD, USA.

ORCID-Profile: Pradeep B Lukka, Robert C Penland, Sherri So, David W Boulton

Zitieren

APA

Lukka, P. B., Penland, R. C., Brekkan, A., Ayoun Alsoud, R., So, S., & Boulton, D. W. (2026). Eosinophilic Depletion with Benralizumab, Mepolizumab, and Depemokimab: A Modeling Study. Journal of Asthma and Allergy, Volume 19, 1-5. https://doi.org/10.2147/jaa.s605634

Vancouver

Lukka PB, Penland RC, Brekkan A, Ayoun Alsoud R, So S, Boulton DW. Eosinophilic Depletion with Benralizumab, Mepolizumab, and Depemokimab: A Modeling Study. Journal of Asthma and Allergy. 2026;Volume 19:1-5. doi:10.2147/jaa.s605634

BibTeX
@article{Lukka2026,
  author = {Lukka, Pradeep B and Penland, Robert C and Brekkan, Ari and Ayoun Alsoud, Rami and So, Sherri and Boulton, David W},
  title = {Eosinophilic Depletion with Benralizumab, Mepolizumab, and Depemokimab: A Modeling Study},
  journal = {Journal of Asthma and Allergy},
  year = {2026},
  volume = {Volume 19},
  pages = {1--5},
  doi = {10.2147/jaa.s605634}
}
Kostenlos starten →